Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
TEMASEK Holdings' unit Ion Investments on Wednesday said it is paring its stakes in two South Korean pharmaceutical companies but will remain a substantial shareholder in both.
Earlier on Tuesday, IFR reported that Ion is selling part of its stakes in Celltrion Inc, and